JP2024502848A5 - - Google Patents

Info

Publication number
JP2024502848A5
JP2024502848A5 JP2023541618A JP2023541618A JP2024502848A5 JP 2024502848 A5 JP2024502848 A5 JP 2024502848A5 JP 2023541618 A JP2023541618 A JP 2023541618A JP 2023541618 A JP2023541618 A JP 2023541618A JP 2024502848 A5 JP2024502848 A5 JP 2024502848A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023541618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502848A (ja
JP7852824B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/050024 external-priority patent/WO2022148725A1/en
Publication of JP2024502848A publication Critical patent/JP2024502848A/ja
Publication of JP2024502848A5 publication Critical patent/JP2024502848A5/ja
Application granted granted Critical
Publication of JP7852824B2 publication Critical patent/JP7852824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023541618A 2021-01-08 2022-01-03 生体吸収性封止粉末 Active JP7852824B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21150755 2021-01-08
EP21150755.3 2021-01-08
PCT/EP2022/050024 WO2022148725A1 (en) 2021-01-08 2022-01-03 Bioresorbable sealing powder

Publications (3)

Publication Number Publication Date
JP2024502848A JP2024502848A (ja) 2024-01-23
JP2024502848A5 true JP2024502848A5 (cg-RX-API-DMAC7.html) 2026-03-04
JP7852824B2 JP7852824B2 (ja) 2026-04-28

Family

ID=74125107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541618A Active JP7852824B2 (ja) 2021-01-08 2022-01-03 生体吸収性封止粉末

Country Status (11)

Country Link
US (1) US20240042094A1 (cg-RX-API-DMAC7.html)
EP (2) EP4274624B1 (cg-RX-API-DMAC7.html)
JP (1) JP7852824B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230130049A (cg-RX-API-DMAC7.html)
CN (1) CN116744983A (cg-RX-API-DMAC7.html)
AU (1) AU2022205500A1 (cg-RX-API-DMAC7.html)
CA (1) CA3207273A1 (cg-RX-API-DMAC7.html)
ES (1) ES2995865T3 (cg-RX-API-DMAC7.html)
IL (1) IL304272A (cg-RX-API-DMAC7.html)
MX (1) MX2023008169A (cg-RX-API-DMAC7.html)
WO (1) WO2022148725A1 (cg-RX-API-DMAC7.html)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022371A1 (en) * 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
NZ550964A (en) * 2004-04-28 2011-05-27 Angiodevice Internat Gmbh Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
TWI436793B (zh) * 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
WO2008125655A1 (en) * 2007-04-13 2008-10-23 Kuros Biosurgery Ag Polymeric tissue sealant
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
BR112013017140B1 (pt) * 2011-01-04 2019-12-17 Bender Analytical Holding Bv polímeros reticulados e implantes provenientes de polioxazolina eletrofilicamente ativada
US8846849B2 (en) * 2011-05-13 2014-09-30 Ethicon, Inc. Tissue sealants from plasma derived proteins
HK1201212A1 (en) * 2011-10-11 2015-08-28 Baxter International Inc Hemostatic compositions
DE102012002209A1 (de) 2012-02-07 2013-08-08 Carl Freudenberg Kg Biodegradierbares Vlies für medizinische Zwecke
US9416228B2 (en) * 2012-03-16 2016-08-16 Bender Analytical Holding B.V. Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
JP6516721B2 (ja) * 2013-03-14 2019-05-22 メディカス バイオサイエンシーズ エルエルシー 固形のポリグリコールをベースとする生体適合性の事前処方物
JP6683398B2 (ja) * 2014-10-06 2020-04-22 ガット テクノロジーズ ビー.ブイ.Gatt Technologies B.V. 組織接着性多孔質止血製品
US10507293B2 (en) 2015-06-24 2019-12-17 Ethicon, Inc. Hemostatic powder delivery devices and methods
CN111265711B (zh) * 2020-03-09 2021-06-15 北京爱特康医疗科技有限公司 一种组织封闭剂粉末、其制备工艺以及组织封闭剂

Similar Documents

Publication Publication Date Title
JP2023512297A5 (cg-RX-API-DMAC7.html)
JP2021008630A5 (cg-RX-API-DMAC7.html)
JP2022544589A5 (cg-RX-API-DMAC7.html)
JP2023538015A5 (cg-RX-API-DMAC7.html)
JP2024510476A5 (cg-RX-API-DMAC7.html)
JP2024510228A5 (cg-RX-API-DMAC7.html)
JPWO2021171942A5 (cg-RX-API-DMAC7.html)
JP2020175021A5 (cg-RX-API-DMAC7.html)
JPWO2021201293A5 (cg-RX-API-DMAC7.html)
JP2024528170A5 (cg-RX-API-DMAC7.html)
JPWO2021152968A5 (cg-RX-API-DMAC7.html)
JP2022522550A5 (cg-RX-API-DMAC7.html)
JP2024077017A5 (cg-RX-API-DMAC7.html)
JPWO2021039602A5 (cg-RX-API-DMAC7.html)
JP2020180208A5 (cg-RX-API-DMAC7.html)
JP2022540681A5 (cg-RX-API-DMAC7.html)
JP2024076480A5 (cg-RX-API-DMAC7.html)
JP2023176349A5 (cg-RX-API-DMAC7.html)
JP2022120819A5 (cg-RX-API-DMAC7.html)
JPWO2021192791A5 (cg-RX-API-DMAC7.html)
JPWO2022054956A5 (cg-RX-API-DMAC7.html)
JP2020147467A5 (cg-RX-API-DMAC7.html)
JPWO2024024534A5 (cg-RX-API-DMAC7.html)
JPWO2022162814A5 (cg-RX-API-DMAC7.html)
JPWO2022202994A5 (cg-RX-API-DMAC7.html)